Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respiratory Medicine

The Lancet Respiratory Medicine, one of the world’s best-known peer-reviewed medical journals has published Medigen Vaccine Biologics (MVC) data from its MVC-COV1901 vaccine phase 2 clinical trial which demonstrates promising immunogenicity and safety profiles. The internationally trusted source of clinical, public and global health knowledge has made available the results from a large-scale, double-blind, randomised, placebo-controlled…

thaipr.net

18 ต.ค. 64

Novavax to Participate in World Vaccine Congress Europe

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a presentation during the World Vaccine Congress Europe 2021. A topic of discussion will be Novavax’ COVID-NanoFlu™ Combination Vaccine, which combines the company’s recombinant…

thaipr.net

18 ต.ค. 64
1 2,616 2,617 2,618 2,619 2,620 3,229